Advanced Oncotherapy (AVO) Selects RayStation for the First LIGHT System in Central London

Source: https://www.prnewswire.com/news-releases/advanced-oncotherapy-avo-selects-raystation-for-the-first-light-system-in-central-london-300676566.html

The UK based developer of next generation proton therapy technology, Advanced Oncotherapy plc (AVO), has selected RayStation as its treatment planning system for the first LIGHT (Linac Image Guided Hadron Technology) system at the proton therapy facility under construction at Harley Street in central London. Users at the clinic will have access to the full spectrum of RayStation’s functionality.

AVO and RaySearch have entered into a collaboration agreement to support the LIGHT system fully. The LIGHT system is a modular proton therapy system based on innovative technology, developed in a collaboration between the TERA project and CERN in Geneva, Switzerland. The heart of the system consists of a treatment room integrated with a linear accelerator, which accelerates protons to energies suitable for radiation therapy of cancer. The entire system is designed for cost effectiveness and low maintenance and has several key features, such as multiple spot sizes and fast energy switching time.

The order of RayStation for Harley street gives the users access to the full spectrum of RayStation’s functionality, including the fast proton Monte Carlo dose engine, robust 4D optimization, LET driven optimization, deformable registration, dose accumulation, plan adaptation, multi-criteria optimization and Plan Explorer for automatic plan generation.

Nicolas Serandour, AVO Chief Executive Officer, says: “We are thrilled to collaborate with RaySearch. RaySearch has established themselves as the technology of choice for light ion therapy treatment planning. As we bring our advanced particle therapy treatment technology into the field, it makes sense to have the most advanced treatment planning capability to complement it. We believe the synergetic combination is significant for optimizing patient care at our first proton therapy center in the renowned medical practice area of Harley Street, London.”

Advertisements

United States Proton Therapy Market Research Report 2018, Market Overview and Forecast up to 2025

Single User License

$900.00

United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$ 7 Billion by 2025.
Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers, decreasing cost of proton therapy treatment, technological advances and market adoption. However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=119
The research report titled “United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States actual and potential proton therapy market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.
The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers from 2008 to 2015.
The report also includes assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.
The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies and recent development & trends of the proton therapy market.
Key Highlights of the United States Proton Therapy Market Report: 
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: United States Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: United States Proton Therapy (2012 – 2025)
• United States Number of Treatment Rooms and Forecast (2012 – 2025)
• United States Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• United States Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• United States Number of Patients Treated at Proton Therapy Centers (2008 – 2015)
• United States Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the United States Proton Therapy Market
• Major Companies Analysis
Key Companies Covered in the Report are as follows:
• Optivus
• Hitachi
• Ion Beam Applications(IBA)
• Varian Medical Systems
• Mevion Medical Systems

IBA and Raysearch showcase the first Online Adaptive Proton Therapy workflow at ESTRO

Source: https://www.dotmed.com/

IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, and RaySearch Laboratories, the global leader in treatment planning software, will demonstrate at the ESTRO congress how they will optimize patient treatment by offering the first online adaptive proton therapy workflow.

IBA and RaySearch will present their full size demonstration including the RayCare oncology information system, the Ray Treatment workflow and treatment planning system, the AdaPT Insight imaging platform and the AdaPT Deliver treatment delivery. In an online adaptive workflow, daily cone beam CT images are used and matched to the planning CT of an individual patient.

This allows to automatically suggest to the care team an adapted treatment plan which takes into account the most up to date patient’s anatomy. This workflow offers more accurate treatment plans as well as faster plan adaptation to the benefit of patients.

Visit for More Reports on Proton Therapy: http://www.dpiresearch.com/

IBA signs three new Proteus ONE contracts with Proton Partners International

Source : https://iba-worldwide.com/

IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces it has signed three new contracts with Proton Partners International (PPI), to install three Proteus ONE compact proton therapy solutions across the UKThe contracts are subject to financing.

The contracted Proteus ONE solutions include Pencil Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities making Proteus ONE the only compact solution ready for adaptive treatment. The contracts also include a maintenance agreement. The typical end-user price for a Proteus ONE solution with a maintenance contract is between EUR 35 and 40 million.

These new centers will be the seventh, eighth and ninth that IBA will install for PPI. IBA has now sold 50 proton therapy centers worldwide, and among them, 21 Proteus ONE compact single-room solutions.

Visit For More Reports on Proton Therapy : http://www.dpiresearch.com/

United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 – 2025

“United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 – 2025” presents an in-depth assessment of the proton therapy market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for Proton Therapy in United States. The research includes historic data from 2012 to 2017 and forecasts until 2025.

Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=128

 

Long–term Growth Projection:
• United States proton therapy market will exhibit growth by a CAGR of over 15% up to 2025
• United States is anticipated to be the most attractive market in the proton therapy market industry
• The potential United States proton therapy market is set to cross USD 7 Billion by 2025
• In 2017, IBA accounted highest number of proton therapy centers in United States
• Hitachi has the second highest number of treatment rooms in United States
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.
The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers.
The report also includes assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.
The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development & trends of the proton therapy market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Hitachi, Optivus, Ion Beam Applications(IBA), Varian Medical Systems, Mevion Medical Systems
The Latest Industry Data Included in this Report:
• Proton Therapy Market Size & Analysis (2012 – 2025)
• Proton Therapy Market Opportunity Assessment (2012 – 2025)
• Number of Treatment Rooms and Forecast (2012 – 2025)
• Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• Major Deals in Proton Therapy Market
• Number of Patients Treated at Proton Therapy Center
• Proton Therapy Reimbursement Scenario
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Key Market Drivers and Inhibitors
• Major Companies Analysis

Japan Proton Therapy Market Research Report Analysis

The report titled “Japan Proton Therapy Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.
Long–term Growth Projection:
• Hitachi and Mitsubishi Electric Agree to Integrate Proton Therapy System Business
• Japan is anticipated to be the most attractive market in the proton therapy industry.
• The potential Japan proton therapy market is likely to reach more than USD 3 Billion by 2025
• Mitsubishi Electric is a technology leader in the field of proton therapy in Japan.
• Hitachi has the second highest share in the treatment rooms segment.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of Japan proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.
The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at Japan proton therapy centers from 2008 to 2016.
The report also includes assessment of Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the Japan proton therapy market.
The report concludes with the profiles of major players in the Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, Japan proton therapy centers developed by the companies and recent development & trends of the proton therapy market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Mitsubishi Electric, Hitachi, Sumitomo Heavy Industries Ltd. and Ion Beam Applications(IBA)
The Latest Industry Data Included in this Report:
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: Japan Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: Japan Proton Therapy (2012 – 2025)
• Japan Number of Treatment Rooms and Forecast (2012 – 2025)
• Japan Proton Therapy Center (Installed Base) and Treatment Room Market
   Share: By Company
• Japan Proton Therapy Center Infrastructure Analysis: Treatment Rooms
   & Proton Therapy Accelerator
• Japan Number of Patients Treated at Proton Therapy Centers (2008 – 2016)
• Japan Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the Japan Proton Therapy Market
• Major Companies Analysis

Japan Proton Therapy Market Research Report Analysis

The report titled “Japan Proton Therapy Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=126
Long–term Growth Projection:
• Hitachi and Mitsubishi Electric Agree to Integrate Proton Therapy System Business
• Japan is anticipated to be the most attractive market in the proton therapy industry.
• The potential Japan proton therapy market is likely to reach more than USD 3 Billion by 2025
• Mitsubishi Electric is a technology leader in the field of proton therapy in Japan.
• Hitachi has the second highest share in the treatment rooms segment.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of Japan proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.
The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at Japan proton therapy centers from 2008 to 2016.
The report also includes assessment of Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the Japan proton therapy market.
The report concludes with the profiles of major players in the Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, Japan proton therapy centers developed by the companies and recent development & trends of the proton therapy market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Mitsubishi Electric, Hitachi, Sumitomo Heavy Industries Ltd. and Ion Beam Applications(IBA)
The Latest Industry Data Included in this Report:
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: Japan Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: Japan Proton Therapy (2012 – 2025)
• Japan Number of Treatment Rooms and Forecast (2012 – 2025)
• Japan Proton Therapy Center (Installed Base) and Treatment Room Market
   Share: By Company
• Japan Proton Therapy Center Infrastructure Analysis: Treatment Rooms
   & Proton Therapy Accelerator
• Japan Number of Patients Treated at Proton Therapy Centers (2008 – 2016)
• Japan Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the Japan Proton Therapy Market
• Major Companies Analysis
Order a Copy of this Report at : http://www.dpiresearch.com/buy.php